Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
about
Donepezil in Alzheimer's disease: From conventional trials to pharmacogeneticsAge-related mild cognitive deficit: a ready-to-use concept?Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?Addressing risk factors of cognitive impairment in adults aging with HIV: a social work model.Thinking Outside the Box in Alzheimer Disease Treatment
P2860
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
description
article
@en
im Jahr 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2002
@uk
name
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
@en
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
@nl
type
label
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
@en
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
@nl
prefLabel
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
@en
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
@nl
P2093
P2860
P356
P1476
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
@en
P2093
John Stirling Meyer
John Thornby
Minh Quach
Munir Chowdhury
Yansheng Li
P2860
P304
P356
10.1002/GPS.652
P407
P50
P577
2002-01-01T00:00:00Z